| Literature DB >> 29853953 |
Nan Liu1,2, Yunyao Jiang2,3, Min Xing4, Baixiao Zhao5, Jincai Hou3, Minyee Lim6, Jian Huang7, Xue Luo4, Li Han4.
Abstract
Aging is closely connected with death, progressive physiological decline, and increased risk of diseases, such as cancer, arteriosclerosis, heart disease, hypertension, and neurodegenerative diseases. It is reported that moxibustion can treat more than 300 kinds of diseases including aging related problems and can improve immune function and physiological functions. The digital gene expression profiling of aged mice with or without moxibustion treatment was investigated and the mechanisms of moxibustion in aged mice were speculated by gene ontology and pathway analysis in the study. Almost 145 million raw reads were obtained by digital gene expression analysis and about 140 million (96.55%) were clean reads. Five differentially expressed genes with an adjusted P value < 0.05 and |log2(fold change)| > 1 were identified between the control and moxibustion groups. They were Gm6563, Gm8116, Rps26-ps1, Nat8f4, and Igkv3-12. Gene ontology analysis was carried out by the GOseq R package and functional annotations of the differentially expressed genes related to translation, mRNA export from nucleus, mRNA transport, nuclear body, acetyltransferase activity, and so on. Kyoto Encyclopedia of Genes and Genomes database was used for pathway analysis and ribosome was the most significantly enriched pathway term.Entities:
Year: 2018 PMID: 29853953 PMCID: PMC5954890 DOI: 10.1155/2018/4767328
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of sequencing analysis.
| Item | C1 | C2 | C3 | M1 | M2 | M3 |
|---|---|---|---|---|---|---|
| Raw reads | 26,827,940 (100%) | 22,683,746 (100%) | 21,586,308 (100%) | 21,008,620 (100%) | 25,584,692 (100%) | 27,045,698 (100%) |
| Clean reads | 25,927,296 (96.64%) | 21,924,166 (96.65%) | 20,808,688 (96.40%) | 20,280,672 (96.54%) | 24,686,554 (96.49%) | 26,115,966 (96.56%) |
| Clean bases | 3.89 G | 3.29 G | 3.12 G | 3.04 G | 3.70 G | 3.92 G |
| Error rate | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Q20 | 97.27% | 97.24% | 97.07% | 97.2% | 97.12% | 97.19% |
| Q30 | 92.97% | 92.92% | 92.63% | 92.86% | 92.7% | 92.84% |
| GC content | 50.55% | 50.32% | 50.86% | 50.59% | 50.34% | 50.34% |
C1, C2, and C3: control group; M1, M2, and M3: moxibustion group. Q20: the percentage of bases with a Phred value > 20; Q30: the percentage of bases with a Phred value > 30.
The data for the sequencing reads that mapped to the reference genome.
| Mapping statistics | C1 | C2 | C3 | M1 | M2 | M3 |
|---|---|---|---|---|---|---|
| Total reads | 25,927,296 (100%) | 21,924,166 (100%) | 20,808,688 (100%) | 20,280,672 (100%) | 24,686,554 (100%) | 26,115,966 (100%) |
| Total mapped | 22,227,826 (85.73%) | 18,834,354 (85.91%) | 17,754,405 (85.32%) | 17,355,918 (85.58%) | 20,950,545 (84.87%) | 22,561,967 (86.39%) |
| Multiple mapped | 1,194,742 (4.61%) | 1,158,291 (5.28%) | 787,789 (3.79%) | 803,162 (3.96%) | 798,262 (3.23%) | 887,175 (3.4%) |
| Uniquely mapped | 21,033,084 (81.12%) | 17,676,063 (80.62%) | 16,966,616 (81.54%) | 16,552,756 (81.62%) | 20,152,283 (81.63%) | 21,674,792 (82.99%) |
| Reads mapped to “+” | 10,510,392 (40.54%) | 8,824,248 (40.25%) | 8,466,976 (40.69%) | 8,262,795 (40.74%) | 10,073,579 (40.81%) | 10,830,805 (41.47%) |
| Reads mapped to “−” | 10,522,692 (40.59%) | 8,851,815 (40.37%) | 8,499,640 (40.85%) | 8,289,961 (40.88%) | 10,078,704 (40.83%) | 10,843,987 (41.52%) |
| Nonsplice reads | 11,296,626 (43.57%) | 10,018,343 (45.7%) | 10,020,095 (48.15%) | 9,453,740 (46.61%) | 11,610,290 (47.03%) | 12,553,211 (48.07%) |
| Splice reads | 9,736,458 (37.55%) | 7,657,720 (34.93%) | 6,946,521 (33.38%) | 7,099,016 (35%) | 8,541,993 (34.6%) | 9,121,581 (34.93%) |
C1, C2, and C3: control group; M1, M2, and M3: moxibustion group. “+” refers to the sense strand, and “−” refers to the antisense strand.
Number of genes at different expression levels.
| FPKM interval | 0~1 | 1~3 | 3~15 | 15~60 | >60 |
|---|---|---|---|---|---|
| C1 | 27263 (67.21%) | 2333 (5.75%) | 4482 (11.05%) | 4403 (10.85%) | 2081 (5.13%) |
| C2 | 26185 (64.56%) | 2510 (6.19%) | 4951 (12.21%) | 4938 (12.17%) | 1978 (4.88%) |
| C3 | 26253 (64.72%) | 2447 (6.03%) | 4742 (11.69%) | 4976 (12.27%) | 2144 (5.29%) |
| M1 | 26524 (65.39%) | 2410 (5.94%) | 4710 (11.61%) | 4808 (11.85%) | 2110 (5.20%) |
| M2 | 26280 (64.79%) | 2437 (6.01%) | 4855 (11.97%) | 4894 (12.07%) | 2096 (5.17%) |
| M3 | 26317 (64.88%) | 2505 (6.18%) | 4724 (11.65%) | 4904 (12.09%) | 2112 (5.21%) |
Figure 1The correlation of FPKM values of all genes between the two replicates of control or moxibustion group. C1, C2, and C3: control group; M1, M2, and M3: moxibustion group. The logarithmic FPKM + 1 values of every gene in the two replicates were assigned as coordinate values of two axes.
List of all the differentially expressed genes between control and moxibustion group.
| Gene ID | Gene name | Read count M | Read count C | Log 2 fold change |
|
| Regulated | Gene annotation |
|---|---|---|---|---|---|---|---|---|
| ENSMUSG00000051255 | Gm6563 | 17.35 | 0.11 | 7.32 | 5.76E − 07 | 0.01 | Up | SAP domain |
|
| ||||||||
| ENSMUSG00000059422 | Gm8116 | 1.35 | 22.08 | −4.03 | 4.26E − 06 | 0.02 | Down | - |
|
| ||||||||
| ENSMUSG00000059775 | Rps26-ps1 | 382.59 | 0.71 | 9.07 | 1.85E − 37 | 4.67E − 33 | Up | Ribosomal protein S26e |
|
| ||||||||
| ENSMUSG00000068299 | Nat8f4 | 54.42 | 8.79 | 2.63 | 3.26E − 06 | 0.02 | Up | GNAT domain, Acyl-CoA N-acyltransferase |
|
| ||||||||
| ENSMUSG00000094117 | Igkv3-12 | 576.18 | 147.63 | 1.96 | 2.25E − 06 | 0.02 | Up | Immunoglobulin subtype, immunoglobulin V-set domain, immunoglobulin-like domain |
Figure 2GO functional enrichment analysis. The differentially expressed genes between control and moxibustion groups were classified based on gene ontology.
Figure 3Pathway map of ribosome in KEGG.